Sherbrooke Park Advisers »

ACADIA Pharmaceuticals shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in ACADIA Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including ACADIA Pharmaceuticals held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ACADIA Pharmaceuticals by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $655k 35k 18.49

More positions owned by Sherbrooke Park Advisers

Johnson & Johnson (JNJ)
Apple (AAPL)
Lennar Corp Cl A (LEN)
Ssr Mining (SSRM)
Smartsheet Com Cl A (SMAR)
Dow (DOW)
Gxo Logistics Incorporated Common Stock (GXO)
Royal Gold (RGLD)
Philip Morris International (PM)
Archer Daniels Midland Company (ADM)
Kraft Heinz (KHC)
Masco Corporation (MAS)
Reynolds Consumer Prods (REYN)
Etsy (ETSY)
Microsoft Corporation (MSFT)

View all positions for Sherbrooke Park Advisers

Top funds holding ACADIA Pharmaceuticals

Baker Bros. Advisors
Vanguard Group
BlackRock
EcoR1 Capital
T. Rowe Price Associates
FMR
Geode Capital Management
D. E. Shaw & Co
Palo Alto Investors
Fred Alger Management
Millennium Management
Emerald Advisers
First Trust Advisors
Jupiter Asset Management
Morgan Stanley

View all funds holding ACADIA Pharmaceuticals